EXEL EXELIXIS, INC.

NEUTRAL Impact: 3/10 Insider Cluster (9 insiders)
Horizon days Filed May 28, 2026 Processed 11d 9h ago
Insider cluster: 2 insiders, $3.8M total
Latest settled — T+5d ⚠ clustered
EXEL ▲ +2.55% at T+5d
NEUTRAL call ✓ call won +2.55% · α vs SPY +2.84% · entry $50.32 → $51.60
Next anchor: T+20d in 16d
Last close $51.74 (close Jun 8) · +2.83% from $50.32 entry
Entry anchored
May 28, 03:59 PM ET
via Databento tick
T+1d
-0.08%
call -0.08% · α -0.35%
$50.28
settled 12d ago
T+5d
+2.55%
call +2.55% · α +2.84%
$51.60
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two EVPs at Exelixis sold a combined $3.79M in open-market sales over a week, while seven directors received non-cash stock grants. The sales represent ~0.03% of market cap, which is trivial relative to the $12.9B company. The cluster is driven by C-suite selling, but the dollar amount is immaterial and likely reflects routine portfolio diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.8M
Insiders
9

Actionable Insight

The insider sales are too small relative to market cap to warrant a bearish read. Monitor for any material corporate events (e.g., earnings, pipeline updates) that could explain the timing, but no immediate action is needed.

Key Facts

  • EVP Patrick J. Haley sold 32,100 shares at $49.81 for $1.60M on 2026-05-20
  • EVP Dana Aftab sold 43,451 shares at $50.35 for $2.19M on 2026-05-26
  • Seven directors received non-cash stock grants totaling 69,335 shares at $0 on 2026-05-27
  • Total open-market sales of $3.79M represent ~0.03% of Exelixis's $12.9B market cap
  • No insider open-market purchases were reported in the cluster

Financial Impact

Open-market sales of $3.79M, or ~0.03% of market cap — immaterial

dilution

Risk Factors

  • C-suite selling could indicate private concerns not yet public, though dollar amount is trivial
  • No insider buying to offset the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EXEL-1780091011818
10 reports for EXEL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EXEL — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $52.69▲ +0.57%▲ +3.17%$51.74 (−1.24%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$50.20 $48.49▼ −3.41%▼ −3.55%$51.74 (+3.07%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.20▼ −0.24%▼ −0.50%$51.74 (+2.83%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $49.82▼ −0.24%▼ −0.25%$51.74 (+3.61%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $49.49▼ −0.80%▼ −1.00%$51.74 (+3.71%)
May 7, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $48.15▲ +4.45%▲ +3.62%$51.74 (+12.24%)
Apr 17, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$43.59 $45.88▲ +5.25%▲ +5.91%$51.74 (+18.70%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$40.98 $40.58▼ −0.98%▼ −0.06%$51.74 (+26.26%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 6h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access